Autoinflammatory diseases: How to put the fire inside the body out?

Autoimmunity Reviews

Volumn 12, Issue 1, 2012, Pages 1-4

  Doria, Andrea ^a   Dayer, Jean Michel ^a,b   Punzi, Leonardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACUTE PHASE PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; COLCHICINE; CORTICOSTEROID; ETANERCEPT; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPER FAMILY 1A; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT ONSET AUTOINFLAMMATORY DISEASE; AMYLOIDOSIS; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BLAU SYNDROME; CHROMOSOME 12P; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG RESPONSE; EARLY DIAGNOSIS; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC SCREENING; GOUT; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC RECURRENT ACUTE PERICARDITIS; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY FAILURE; LOW DRUG DOSE; ONSET AGE; PALLIATIVE THERAPY; PATHOGENESIS; PERICARDITIS; PFAPA SYNDROME; PROTEIN BLOOD LEVEL; PROTEINURIA; RECURRENT DISEASE; REVIEW; SINGLE DRUG DOSE; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; INFLAMMASOMES; MUTATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84866863636     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.07.013     Document Type: Review

References (24)

1. Galeazzi M., Gasbarrini G., Ghirardello A., Grandemange S., Hoffman H.M., Manna R., et al. Autoinflammatory syndromes. Clin Exp Rheumatol 2006, 24:S79-S85.
2. Efthimiou P., Flavell R.A., Furlan A., Gasbarrini G., Gava A., Koné-Paut I., et al. Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 2008, 26(Suppl. 48):S53-S61.
3. Sarzi-Puttini P., Atzeni F., Iaccarino L., Doria A. Environment and systemic lupus erythematosus: an overview. Autoimmunity 2005, 38:465-472.
4. Rekvig O.P., Putterman C., Casu C., Gao H.X., Ghirardello A., Mortensen E.S., et al. Autoantibodies in lupus: culprits or passive bystanders?. Autoimmun Rev 2012, 11:596-603.
5. Doria A., Sarzi-Puttini P., Shoenfeld Y. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 2008, 8:1-4.
6. Toitou I. New genetic interpretation of old diseases. Autoimmun Rev: 2012, 12:5-9. (this issue).
7. Muscari I., Iacoponi F., Cantarini L., Lucherini O.M., Simonini G., Brizi M.G., et al. The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev: 2012, 12:10-13. (this issue).
8. Merlini G.P., Obici L. The amyloidosis in autoinflammatory syndromes. Autoimmun Rev: 2012, 12:14-17. (this issue).
9. Doria A., Zen M., Iaccarino L., Bettio S., Gatto M., Bassi N., et al. Autoinflammation and autoimmunity: Bridging the divide. Autoimmun Rev: 2012, 12:22-30. (this issue).
10. Ghirardello A., Doria A., Zampieri S., Tarricone E., Tozzoli R., Villalta D., et al. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 2004, 22:235-240.
11. Zampieri S., Degen W., Ghirardello A., Doria A., van Venrooij W.J. Dephosphorylation of autoantigenic ribosomal P proteins during FAS-L induced apoptosis; a possible trigger for the development of the autoimmune response in SLE patients. Ann Rheum Dis 2001, 60:72-76.
12. Doria A., Zen M., Canova M., Bettio S., Bassi N., Nalotto L., et al. SLE diagnosis and treatment: When early is early. Autoimmun Rev 2010, 10:55-60.
13. Soriano A., Manna R. Familial Mediterranean fever: new phenotypes. Autoimmun Rev: 2012, 12:31-37.
14. Cantarini L., Lucherini O.M., Muscari I., Frediani B., Galeazzi M., Brizi M.G., et al. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev: 2012, 12:38-43. (this issue).
15. Sfriso P., Caso F., Tognon S., Galozzi P., Gava A., Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev: 2012, 12:44-51. (this issue).
16. Vigo G., Zulian F. Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA). Autoimmun Rev: 2012, 12:52-55. (this issue).
17. Martini A. Systemic juvenile idiopathic arthritis. Autoimmun Rev: 2012, 12:56-59. (this issue).
18. Caforio A.L., Brucato A., Doria A., Brambilla G., Angelini A., Ghirardello A., et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 2010, 96:779-784.
19. Maestroni S., Di Corato P.R., Cumetti D., Salvatore S., Ghidoni S., Prisacaru L., et al. Recurrent pericarditis: autoimmune or autoinflammatory?. Autoimmun Rev: 2012, 12:60-65. (this issue).
20. Cantarini L., Lucherini O.M., Brucato A., Barone L., Cumetti D., Iacoponi F., et al. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol 2012, 101:525-531.
21. Punzi L., Scanu A., Ramonda R., Oliviero F. Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets. Autoimmun Rev: 2012, 12:66-71. (this issue).
22. Lidar M., Yonath H., Shechter N., Sikron F., Sadetzki S., Langevitz P., et al. Incomplete response to colchicine in M694V homozygote FMF patients. Autoimmun Rev: 2012, 12:72-76. (this issue).
23. Konè-Paut I., Piram M. Targeting interleukin-1β in CAPS [cryopyrin-associated periodic] syndromes. What did we learn?. Autoimmun Rev: 2012, 12:77-80. (this issue).
24. Caorsi R., Federici S., Gattorno M. Biologic drugs in autoinflammatory syndromes. Autoimmun Rev: 2012, 12:81-86. (this issue).